.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The evolution of biotechnology has reached a significant milestone with AbNatiV2 antibody design. This deep learning tool assesses the "nativeness" of candidate sequences to ensure pharmaceutical stability and low toxicity. Natural immune systems produce antibodies that balance binding strength with minimal self-reactivity. However, identifying these optimal candidates manually remains a complex challenge. Consequently, researchers now use nativeness scoring to select developable leads from synthetic libraries efficiently.
While the original AbNatiV model established a baseline for nativeness assessment, it faced limitations with unpaired sequences. Therefore, experts developed AbNatiV2 by training the architecture on over 20 million sequences. This enhanced version significantly improves classification across diverse test sets. Moreover, it accurately detects subtle changes in nativeness during the CDR grafting process. Furthermore, the model helps identify candidates that are less likely to cause adverse reactions in patients by mimicking natural repertoires.
The introduction of the p-AbNatiV2 model marks a substantial leap forward for conventional antibody engineering. This cross-attention model was fine-tuned on nearly 4 million paired human sequences. Specifically, it assesses the likelihood of VH/VL pairing with remarkable precision. In held-out tests, the system correctly identifies native pairs 74% of the time. Thus, it outperforms most existing pairing models used in the industry today.
In addition, clinicians and biotech researchers can leverage this tool for humanization and de novo design. By ensuring sequences look "native," they minimize the risk of immunogenicity. This is critical for the safety of new monoclonal antibody therapies. This tool supports design decisions at the single-residue, Fv-sequence, and paired-domain levels. Consequently, AbNatiV2 represents an essential asset for modern biopharmaceutical research and development.
Nativeness refers to how closely a synthetic antibody sequence matches those found in natural human or camelid immune systems. High nativeness scores usually correlate with better folding, stability, and lower toxicity.
AbNatiV2 utilizes an expanded dataset of 20 million sequences and introduces p-AbNatiV2. This new component handles paired VH-VL sequences, allowing for more accurate conventional antibody assessment compared to the unpaired AbNatiV1.
The model was trained on newly sequenced and curated camelid repertoires. Therefore, it offers robust classification for nanobodies, helping researchers identify stable single-domain antibodies for therapeutic use.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or endorsement of any specific software or treatment. Refer to the latest local and national guidelines for clinical practice.
References
1. Ramon A et al. Deep learning assessment of nativeness and pairing likelihood for antibody and nanobody design with AbNatiV2. MAbs. 2026 Dec 31. doi: 10.1080/19420862.2026.2646361. PMID: 41947016.
2. Ramon A, et al. AbNatiV: VQ-VAE-based assessment of antibody and nanobody nativeness for hit selection, humanisation, and engineering. bioRxiv. 2025. doi: 10.1101/2025.10.31.685806.
3. Shin JE, et al. Machine Learning Models for Nanobody Developability Trained on a Custom Multi-Readout Dataset. BioLogic Summit. 2026.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AbNatiV2 uses deep learning to evaluate antibody and nanobody nativeness, streamlining the design of stable, low-toxicity therapeutic candidates....
3 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
